{"status":"success","data":{"title":"Subarachnoid Hemorrhage, Nontraumatic","slug":"subarachnoid-hemorrhage-nontraumatic","tags":null,"collection":["Neurology"],"content":"<h1 id=\"subarachnoid-hemorrhage-nontraumatic-high-risk-characteristics\">Subarachnoid Hemorrhage, Nontraumatic: High Risk Characteristics</h1>\n<p>Consider SAH if patient presents with  <strong>at least 1 of the 7  </strong>unique high-risk characteristics, based on the 3 models**: </p>\n<table>\n<colgroup>\n<col width=\"100%\" />\n</colgroup>\n<tbody>\n<tr class=\"odd\">\n<td><ul>\n<li>Age ≥ 40 years</li>\n<li>Witnessed loss of consciousness</li>\n<li>Neck pain or stiffness</li>\n<li>Onset of HA with exertion</li>\n<li>Arrival by ambulance</li>\n<li>Vomiting</li>\n<li>DBP ≥ 100mmHg or SBP ≥ 160mmHg </li>\n</ul></td>\n</tr>\n</tbody>\n</table>\n\n<h2 id=\"study-details\">Study Details</h2>\n<p><strong>Study design</strong></p>\n<ul>\n<li>Multicenter (6) prospective cohort study over 5 years</li>\n</ul>\n<p><strong>Inclusion criteria</strong></p>\n<ul>\n<li>Neurologically intact adults (age ≥ 16 years) with a non-traumatic headache peaking within an hour</li>\n</ul>\n<p><strong>Exclusion criteria</strong></p>\n<ul>\n<li>History of ≥ 3 recurrent HA’s of same character/intensity</li>\n<li>Referred from another hospital with confirmed SAH</li>\n<li>Returned for reassessment of same HA which was already evaluated for SAH </li>\n<li>Papilledema</li>\n<li>New focal neurologic deficits</li>\n<li>Previous diagnosis of cerebral aneurysm or SAH</li>\n<li>Previous diagnosis of brain neoplasm</li>\n<li>Known hydrocephalus </li>\n</ul>\n<p><strong>Outcome measures</strong></p>\n<!-- -->\n<ul>\n<li>SAH by CT</li>\n<li>Xanthochromia</li>\n<li>RBC in LP plus positive angiogram</li>\n</ul>\n<p><img src=\"https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/fb036f85-428e-5bd9-adc2-73b0aa043d25/640.png\" alt=\"\"></p>\n<h2 id=\"study-results\">Study Results</h2>\n<ul>\n<li>130 of 1999 (6.5%) patients had a SAH</li>\n<li>1546/1999 (78.5%) of all HA patients said that it was the “worst HA of their life” </li>\n<li><span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001503\">3 models were associated with SAH with a sensitivity of 100%</span></li>\n</ul>\n<p><strong>Model 1:</strong> (sensitivity 100%, specificity 28.4%, NPV 100%) </p>\n<ul>\n<li>Age ≥ 40 years</li>\n<li>Neck pain or stiffness</li>\n<li>Witnessed loss of consciousness  </li>\n<li>Onset of HA with exertion</li>\n</ul>\n<p><strong>Model 2:</strong> (sensitivity 100%, specificity 36.5%, NPV 100%) </p>\n<ul>\n<li>Arrival by ambulance</li>\n<li>Age ≥ 45 years</li>\n<li>Vomiting at least once </li>\n<li>DBP ≥ 100 mmHg</li>\n</ul>\n<p><strong>Model 3:</strong> (sensitivity 100%, specificity 38.8%, NPV 100%)</p>\n<ul>\n<li>Arrival by ambulance</li>\n<li>SBP ≥ 160 mmHg</li>\n<li>Neck pain or stiffness</li>\n<li>Age 45-55 years </li>\n</ul>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=21030443\">Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Lee JS, Eisenhauer M, Symington C, Mortensen M, Sutherland J, Lesiuk H, Wells GA. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ. 2010 Oct 28;341:c5204. doi: 10.1136/bmj.c5204.</a></li>\n</ul>\n"}}